ERBB2 and neoplasm: HER2 activation triggers key signaling pathways, including PI3K/AKT/mTOR19 and RAS–RAF–MEK–ERK,20 which drive tumor cell proliferation, inhibit apoptosis, and influence tumor growth, survival, and metastasis.21, 22